Data Year:

For its 2025 fiscal year, NRC HEALTH, listed the following executives on its annual proxy statement to the SEC

Equity
Cash Compensation
Other
Fiscal Year Ended in 2025
Name And Title Total Compensation Pay Rank By Title In Business Services industry
Michael D. Hays
Chair; Former Chief Executive Officer, President
Total Compensation $184,416 View details Pay Rank By Title In Business Services industry #21 View more
Helen L. Hrdy
EVP & Chief Operating Officer
Total Compensation $2,474,847 View details Pay Rank By Title In Business Services industry #93 View more
Linda Stacy
Former Interim Principal Financial Officer
Total Compensation $59,997 View details Pay Rank By Title In Business Services industry #623 View more
Andy Monnich
EVP & Chief Corporate Development Officer
Total Compensation $2,474,817 View details Pay Rank By Title In Business Services industry #93 View more
Shane Harrison
Chief Financial Officer
Total Compensation $2,481,100 View details Pay Rank By Title In Business Services industry #305 View more
Trent Green
Chief Executive Officer
Total Compensation $11,961,900 View details Pay Rank By Title In Business Services industry #144 View more
Jason Rau
Executive Vice President, Sales
Total Compensation $619,133 View details Pay Rank By Title In Business Services industry #168 View more

The charts on this page feature a breakdown of the total annual pay for the top executives at NRC HEALTH as reported in their proxy statements.

Total Cash Compensation information is comprised of yearly Base Pay and Bonuses. NRC HEALTH income statements for executive base pay and bonus are filed yearly with the SEC in the edgar filing system. NRC HEALTH annual reports of executive compensation and pay are most commonly found in the Def 14a documents.

Total Equity aggregates grant date fair value of stock and option awards and long term incentives granted during the fiscal year.

Other Compensation covers all compensation-like awards that don't fit in any of these other standard categories. Numbers reported do not include change in pension value and non-qualified deferred compensation earnings.

Name And Title Total Cash Equity Other Total Compensation
Michael D. Hays
Chair; Former Chief Executive Officer, President
Total Cash $127,400 Equity $54,554 Other $2,462 $184,416
Helen L. Hrdy
EVP & Chief Operating Officer
Total Cash $1,226,667 Equity $1,240,000 Other $8,180 $2,474,847
Linda Stacy
Former Interim Principal Financial Officer
Total Cash $12,500 Equity $0 Other $47,497 $59,997
Andy Monnich
EVP & Chief Corporate Development Officer
Total Cash $1,226,667 Equity $1,240,000 Other $8,150 $2,474,817
Shane Harrison
Chief Financial Officer
Total Cash $192,308 Equity $2,287,600 Other $1,192 $2,481,100
Trent Green
Chief Executive Officer
Total Cash $5,200,448 Equity $6,755,000 Other $6,452 $11,961,900
Jason Rau
Executive Vice President, Sales
Total Cash $611,823 Equity $0 Other $7,310 $619,133
For its 2025 fiscal year, NRC HEALTH, listed the following CEO pay ratio data on its annual proxy statement to the SEC.
CEO Name CEO Pay Median Employee Pay CEO Pay Ratio
Trent Green CEO Pay $11,961,900 Median Employee Pay $87,276 CEO Pay Ratio 137:1
For its 2024 fiscal year, NRC HEALTH, listed the following board members on its annual proxy statement to the SEC.
Name Total COMPENSATION
Donald M. Berwick Total Cash $175,008
John N. Nunnelly Total Cash $200,008
Parul Bhandari Total Cash $175,008
Penny A. Wheeler Total Cash $175,008
Stephen H. Lockhart Total Cash $175,008
Browse Board of Directors By First Name
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
Browse Executives by First Name
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
Browse Companies by Company Name
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

This report is not for commercial use. Thorough reviews have been conducted to assure this data accurately reflects disclosures. However for a complete and definitive understanding of the pay practices of any company, users should refer directly to the actual, complete proxy statement.

Use of Data / Disclaimer

The information shown here is a reporting of information included in the company's proxy statement. The proxy statement includes footnotes and explanations of this information plus other information that is pertinent in assessing the overall value and appropriateness of the compensation information. For those interested in conducting a detailed compensation analysis, we recommend that you review the entire proxy statement. You may retrieve the full proxy statement by going to the Securities and Exchange Commission (SEC) website at www.sec.gov and entering the company's name and then looking in the first column for an entry of "Form DEF 14A" (or any similar code). You may also find the annual proxy statement by going directly to the company's website.

What is a proxy statement?

A proxy statement (or "proxy") is a form that every publicly traded U.S. company is required to file with the U.S. Securities & Exchange Commission (SEC) within 120 days after the end of its fiscal year. The proxy must be sent to every shareholder in advance of the company's annual shareholders meeting. All proxy statements are public filings made available to the general public by the SEC.

The proxy statement's main purpose is to alert shareholders to the annual meeting and provide them information about the issues that will be voted on during the annual meeting, including decisions such as electing directors, ratifying the selection of auditors, and other shareholder-related decisions, including shareholder-initiated initiatives. Also, proxies must disclose specific detailed information regarding the pay practices for certain executives.